Objectives-To investigate the stiffness of human prostate cancer in a xenograft implantation model using shear wave elastography and compare the pathologic features of tumors with varying elasticity.
cancer include prostate-specific antigen screening, digital rectal examination, and imaging results. Widespread use of the prostate-specific antigen test for prostate cancer may lead to overdiagnosis and overtreatment. 3 Digital rectal examination cannot detect early prostate cancer lesions, which are not stiff enough. With the rapid development of modern medical imaging, diagnostic imaging can provide useful clues for early and differential cancer diagnosis. Shear wave elastography (SWE) is a novel technique that can assess tissue stiffness and is increasingly applied in the detection of cancer. 4 Shear wave elastography excited by an acoustic radiation force impulse can provide a quantitative measurement of the Young modulus of tissue, which is related to the shear wave velocity, and can create a color image of tissue stiffness. 5, 6 Compared to strain elastography and acoustic radiation force impulse imaging, SWE could provide a quantitative estimate of a tissue's elastic modulus. 6 Shear wave elastography has some advantages in diagnoses of liver diseases, 7 breast masses, 8 thyroid nodules, 9 and chronic kidney disease. 10 It is also a very important technique for detecting prostate cancer and guiding biopsy of prostate cancer. Several studies have shown that ultrasound elastography can distinguish malignant disease from benign disease in the prostate. 11 Moreover, SWE can provide quantitative elasticity values of prostate cancer tissue without manual compression. 12 Although the sensitivity, specificity, negative predictive value, and positive predictive value of SWE in prostate cancer detection were different, [13] [14] [15] those findings may be associated with the pathologic features of lesions such as prostatitis, fibrosis, cell hyperplasia, and the extracellular matrix (ECM).
The ECM is a crucial factor for stiffness of cancer tissue. Zhou et al 16 claimed that the "stiff rim" sign was a special feature of breast lesions on SWE. Research showed that the changes in the ECM were closely related to cancer metastasis. 17 However, the pathologic characteristics of tissue stiffness in prostate cancer are not very clear. Our previous clinical studies demonstrated that the tissue hardness of prostatic tumors evaluated by strain elastography was mainly dependent on the content of collagen type I. 18 It is expected that SWE could provide quantitative elastic parameters of the ECM in prostate cancer for predicting tumor metastasis.
In this study, we aimed to investigate the stiffness of human prostate cancer tissue in a xenograft implantation model using SWE in a feasibility study for further research. We also analyzed stromal content and attempted to provide an explanation for the pathologic characteristics on SWE in prostate cancer.
Materials and Methods

Cell Culture
The human DU-145 prostate cancer cell line was provided by J. Q. Zhou from the Beijing Institute of Biotechnology (Beijing, China). The cells were cultured in Dulbecco's modified Eagle's medium (Gibco, Grand Island, NY) supplemented with 10% fetal bovine serum (HyClone Laboratories, Inc, Logan, UT) and 1% Lglutamine. At 80% to 90% confluency, cells were trypsinized for xenograft implantation. All cells were maintained in humidified atmosphere of 95% air plus 5% carbon dioxide at 378C.
Animals
Twenty-four male nude mice aged between 4 and 6 weeks old and weighing 18 to 20 g were obtained from the laboratory animal center of the Beijing Institute of Radiation Medicine with a health certificate (license number SCXK 2012-0004). The research was approved by the Ethics Committee of the Chinese PLA General Hospital, and the mice were treated and cared for in accordance with the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals.
Xenograft Implantation Model DU-145 prostate cancer cells (5 3 10 6 ) in a 0.2-mL solution of normal saline were implanted in the right inguen of each mouse. The mice were randomly divided into 3 groups (8 mice per group) according to the observation time. After collection of sonograms of tumors, the mice were euthanized at 6, 8, and 10 weeks, respectively, after implantation to analyze their pathologic properties.
B-Mode Sonography and SWE
Sonographic examinations were performed at 6, 8, and 10 weeks after transplantation of human prostate cancer cells. B-mode and SWE images were acquired with an Axiplorer ultrasound system 19 (SuperSonic Imagine, Aix-en-Provence, France) with a 4-15-MHz linear array transducer. After the mice were anaesthetized with pentobarbital sodium by intraperitoneal injection, tumor sizes were measured at the maximum tumor section and the volumes were calculated according to the formula (width 3 height 3 length 3 p/6). Then the real-time tissue elastographic mode was switched on, and a colorcoded semitransparent SWE image was overlaid on the corresponding grayscale image. The transducer was then placed on a height-adjustable shelve, thereby eliminating physiologic movement from the hand. The transducer was adjusted to the surface of the tumors for 3 to 5 seconds without any change in shape. The SWE scale was set to a maximum value of 180 kPa. Square elasticity boxes (color-coded maps) including the tumors were set on the color SWE images. A color-coded map was rebuilt to show tissue elasticity, with the area that was blue representing soft tissue and the area that was red representing hard tissue. One circular region of interest was placed on the tumor by hand to obtain the average Young modulus value. The region of interest included the largest possible portion of the tumor as seen on grayscale image. The Young modulus was automatically calculated and visualized by the SWE system. The size and average Young modulus value of every tumor were automatically calculated by the SWE system. We measured 3 times, and the mean value was used for evaluation of reproducibility. The examinations were performed by 2 experienced independent researchers.
Pathologic Analysis
The mice were euthanized at 6, 8, and 10 weeks after transplantation, and the tumors were collected. Tumors were fixed in 10% formaldehyde at room temperature. The tissues were then embedded in paraffin. The samples were used for hematoxylin-eosin staining in parallel with Ponceau S, and aniline blue (Beijing Chemical Industry Group, Beijing, China) double staining to display collagen and elastic fibers and picric acid-sirius red (Beijing Chemical Industry Group) to stain collagen types I and III. 18 Furthermore, immunohistochemistry of vimentin (1:500; Cell Signaling Technology, Inc, Danvers, MA) and a-smooth muscle actin (a-SMA, 1:500; Abcam, Cambridge, England) was performed to analyze smooth muscle cells and myofibroblasts in the tumors.
The scores of the staining results were based on the following criteria as described in a previous study 20 : (1) percentage of positive tumor cells in the tumor tissue-0 (0%), 1 (1%-10%), 2 (11%-50%), 3 (51%-70%), and 4 (71%-100%); and (2) staining intensity-0 (none), 1 (weak), 2 (moderate), and 3 (strong). The staining index was calculated as follows: staining intensity score 3 proportion of positive tumor cells. A final score of 5 or higher was considered as high expression.
Images were visualized on a polarized microscope (6000B; Leica DM, Oberkochen, Germany). The area ratios of elastic fibers, collagen fibers, and collagen I and III were analyzed with Leica Qwin 3.4 image software. Three randomly selected images per section were captured (magnification 3400). The pathologic data were analyzed by 2 independent pathologists, who were blinded to the sonographic parameters of the tumors.
Statistical Analysis
Quantitative data are shown as mean 6 standard deviation. The volumes and Young modulus were analyzed by 1-way analysis of variance. Statistical comparisons between the 3 groups were analyzed by a post hoc test. To assess non-normally distributed data for the area ratios of collagen I/III, the Kruskal-Wallis method was performed. The correlation of the Young modulus with the area ratios of collagen I/III was evaluated by Spearman rank correlation. All analyses were performed with SPSS version 12.0 software for Windows (IBM Corporation, Armonk, NY). P < .05 was considered statistically significant.
Results
Xenograft Implantation Model of DU-145 Prostate Cancer Cells DU-145 prostate cancer cells were injected into 24 mice to establish a prostate cancer xenograft implantation model. Transplanted cells were in the logarithmic phase. Nodules were observed at the seventh day after cell implantation. The tumors were formed at the fourth week and grew rapidly after that time (Figure 1 ). There were accidental deaths in all 3 groups, resulting in a total of 19 tumors available for analysis.
B-Mode Sonography and Elastography of the Tumors in the Prostate Cancer Xenograft Model
The tumor sizes were measured in the maximum tumor sections with B-mode sonography ( Figure 2 ). As shown in Table 1 , the volumes of the tumors increased dramatically with the transplantation time. The stiffness of tumor tissue was quantitatively evaluated by the Young modulus (Figure 2) . The Young modulus increased with the tumor size and implantation time (Table 1 ). There were significant differences in the Young modulus between groups 3 and 1.
Fiber Composition of Tumors in the Prostate Cancer Xenograft Model
To investigate the tumor composition, Ponceau S and aniline blue double staining was used to stain elastic (red) and collagen (blue) fibers (Figure 3) . Picric acidsirius red staining was used to display collagen types I and III. Under the polarized light microscope, collagen I was displayed as red or yellow, and collagen III was displayed as green (Figure 3) . The area ratios of collagen I/ III were calculated (Table 1) for analyzing the type of collagen fibers contributing to tumor elasticity. In group 3, the area ratio of collagen I/III was significantly higher than that of group 1. The area ratios of collagen I/III had a higher correlation with the average Young modulus of the tumors (Figure 4) . As the area ratio of collagen I/III increased, the Young modulus of the tumors increased significantly.
Fibroblasts and Smooth Muscle Cells of Tumors in the Prostate Cancer Xenograft Model
To analyze the critical fibroblasts and smooth muscle cells in the EMC, immunohistochemistry of vimentin and a-SMA was performed ( Figure 5 ). The average vimentin expression scores in the 3 groups were 1.33, 1.50, and 1.67. According to the score criteria, the expression levels of vimentin in the 3 groups were low (scores <5). The average a-SMA scores in the 3 groups were 2.33, 2.50, and 7.67. The expression level of a-SMA was high in group 3 (score >5), 
(A), 2 (B), and 3 (C). D-F, Fiber composition of tumors by Ponceau S and aniline blue double staining of groups 1 (D), 2 (E), and 3 (F). Red arrows indicate elastic fibers (red), and black arrows indicate collagen fibers (blue). G-I, Collagen types I and III displayed by picric acid-sirius red staining of groups 1 (G), 2 (H), and 3 (I).
and the expression levels were low in groups 1 and 2 (score <5).
Discussion
Prostate cancer is one of the malignant tumors that is a threat to the health of older men worldwide. 1 It is well known that digital rectal examination is the oldest and least-invasive test for the diagnosis of prostate cancer. It is based on the crucial factor that prostate cancer tissue is stiffer than normal prostate tissue. 21, 22 In recent years, imaging had played an important role in the detection of prostate cancer. Elastography as one of the novel imaging technologies that can distinguish tissue stiffness in real time. 4 Elastography can clearly indicate the stiffness of nodules, especially those that are less stiff in the early stage of prostate cancer, which are not detected by digital rectal examination. In addition, SWE can provide quantitative tissue elasticity parameters by way of the Young modulus, which is related to the speed of the shear wave through the tissue. Shear wave elastography is based on the combination of acoustic radiation force and an ultrafast imaging sequence, which is capable of detecting the propagation of the resulting shear waves without mechanical external compression. 19 Our previous study found that the Young modulus of prostatic tissue increased during benign prostatic hyperplasia and verified that there was a significant correlation between the Young modulus and the degree of bladder outlet obstruction. 23 In addition, SWE is also a useful imaging technology in detection of prostate cancer. A recent report demonstrated that SWE allowed the identification of prostate cancer foci based on SWE differences, and the researchers also identified valid cutoffs for recognition of prostate cancer foci. 12 Correas et al 13 claimed that a 35-kPa threshold on SWE may provide additional information for detection and biopsy guidance of prostate cancer. Boehm et al 24 demonstrated that SWE may be helpful in selecting patients for biopsy. However, the diagnostic capabilities of SWE were different, and the pathologic bases were not clear enough. Factors such as prostatitis, fibrosis, and atrophy can be associated with increased stiffness on elastography. 25 It is worth doing some basic research on the correlation between pathologic characteristics and the stiffness of prostate cancer. In this study, the elasticity of prostate cancer xenograft tumors was recorded by SWE. According to a previous study, the mice were divided into 3 groups according to growth time. 26 We measured the tumor size by B-mode sonography in this study and found that the tumor volume rapidly enlarged and the Young modulus increased as time progressed. Factors contributing to the increased Young modulus could include tumor size, number of cancer cells, growth time, and surrounding tissue composition. We also observed that some necrosis in larger tumors could decrease the Young modulus. In our future work, we will record more detailed information and further analyze the effect of necrosis.
Data regarding the pathologic basis of prostate cancer on elastography are limited. Previous studies showed that cancer cells were softer than normal cells, whereas tumor tissues were stiffer than normal tissues. 27 The researchers focused attention on the viewpoint that the stiffness of tumor tissue partly depends on the components of the ECM. The balance between ECM deposition and ECM degradation is important for tissue homeostasis, whereas it is disturbed in oncogenesis. 28 Most important, the ECM components are closely related to tumor progression, growth, cell migration, invasion, and angiogenesis. 29 Researchers claimed that the main components of collagen and elastic fibers provide mechanical strength and flexibility to tissue. 30 One study found that collagen became stiffer as it was stretched and deemed that collagen could resist tensile stress. 31 Provenzano et al 32 demonstrated that tissue becomes stiffer with the deposition of certain collagen subtypes and linearization of collagen fibrils. Our previous research also indicated that collagen I is responsible for the stiffness of human prostate cancer tissues. 18, 33 In this study, prostate cancer tumor growth was successfully established in a prostate cancer xenograft model in vivo. Different components of fibers in tumors at different growth times were analyzed by double staining and picric acid-sirius red staining. There were fewer elastic fibers and more collagen fibers in stiffer tumor tissues than in softer tumors. Among the 4 types of collagen, type I is deemed to play a critical role in the remodeling of tumors. Increased collagen type I is the main component in rigid and less compressible tissue, 34, 35 which was also detected in our study. Differences in the pathologic features between stiff tissue and soft tissue can be evaluated by elastography; remodeling in the ECM of a tumor can be an important factor on elastography.
In addition, cells in the tumor stroma contribute to tumor elasticity. The prostatic stroma is composed of cells that secrete growth factors and produce ECM components, such as fibroblasts, myofibroblasts, and smooth muscle cells. 36 Fibroblasts are the most common cell type of the connective tissues. 37, 38 They can secrete growth factors that affect the ECM and remodel the connective tissue around the tumor. That process allows cancerous cells to escape from the primary focus to the vascular system, thereby promoting tumor metastasis and progression. 17, 39 Specifically, fibrocytes can produce matrix proteins such as vimentin and collagen I and III. They participate in the remodeling response by secreting matrix metalloproteinases. 40 With the recognition of the importance of the ECM in cancer, the theory of cancer-associated fibroblasts was proposed. Cancer-associated fibroblasts can secrete a variety of ECM components to form the desmoplastic stroma, which is a characteristic of many advanced carcinomas. 41 Cancer-associated fibroblasts are mainly identified by their cellular morphologic characteristics and the expression of a-SMA, vimentin, and fibroblast-activating protein. 42 We detected the expression of a-SMA in prostate cancer xenograft tumors. The results demonstrated that a-SMA expression was higher in stiff tissues than in soft tissues. Although vimentin expression was negative, and fibroblast-activating protein was not detected in this study, we conclude that there might have been some cancer-associated fibroblasts in the a-SMApositive cells. Therefore, we will analyze this point in our future experiments. Cells in tumor stroma, especially cancer-associated fibroblasts, are important regulatory factors for ECM remodeling.
There were some limitations in this study. First, we did not investigate the organization of the collagen or the mechanical strength of the fibers in the tumors and only observed the disorder of the fibers in the tumors. However, the aim of this study was to distinguish the different elasticities of prostate cancer xenograft tumors and to analyze their pathologic features. Second, there are still some differences between xenograft tumors in animals and the tissues in patients with prostate cancer. The growth times are different. The growth of a human tumor is a relatively long process, whereas the growth time in this model is only 1 to 3 months. Otherwise, the immune system may play a role during the human prostate cancer growth process, although we could not know how it works in this study. Therefore, in this study, we were only able to mimic a tumor growth environment in vivo and describe some tumor characteristics obtained by elastography as a feasibility study for further research.
In conclusion, the data from this study suggest that it is feasible to determine elasticity features of human prostate cancer xenograft tumors by SWE, and SWE is a useful method to evaluate the stiffness of tumors in the model. Pathologic differences exist in the stiff and soft tumors identified by SWE. Elastography can be a useful technique for detecting prostate cancer.
